BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31380426)

  • 1. Tumor Microenvironment and Cell Fusion.
    Jiang E; Yan T; Xu Z; Shang Z
    Biomed Res Int; 2019; 2019():5013592. PubMed ID: 31380426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eph Receptors: Actors in Tumor Microenvironment.
    Zhou X; Tu P; Chen X; Guo S; Wang J
    Crit Rev Oncog; 2017; 22(5-6):499-505. PubMed ID: 29604927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
    Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
    Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming resistance of cancer stem cells.
    Pignalosa D; Durante M
    Lancet Oncol; 2012 May; 13(5):e187-8. PubMed ID: 22554542
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cellular mechanisms and regulation of metastasis formation].
    Chikina AS; Aleksandrova AIu
    Mol Biol (Mosk); 2014; 48(2):195-213. PubMed ID: 25850289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression.
    Cui D; Huang Z; Liu Y; Ouyang G
    Cell Mol Life Sci; 2017 Dec; 74(23):4287-4291. PubMed ID: 28884337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic alterations in tumor stroma.
    Eng C; Leone G; Orloff MS; Ostrowski MC
    Cancer Res; 2009 Sep; 69(17):6759-64. PubMed ID: 19706759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing intra-tumoral heterogeneity and therapy resistance.
    Rybinski B; Yun K
    Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment.
    Qian Z; Shen Q; Yang X; Qiu Y; Zhang W
    Biomed Res Int; 2015; 2015():649161. PubMed ID: 26582468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor microenvironment is a dominant force in multidrug resistance.
    Correia AL; Bissell MJ
    Drug Resist Updat; 2012; 15(1-2):39-49. PubMed ID: 22335920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.
    Kohlhapp FJ; Mitra AK; Lengyel E; Peter ME
    Oncogene; 2015 Nov; 34(48):5857-68. PubMed ID: 25867073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence cancer stem cells--made by cell fusion?
    Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
    Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-microenvironmental interactions: paths to progression and targets for treatment.
    Box C; Rogers SJ; Mendiola M; Eccles SA
    Semin Cancer Biol; 2010 Jun; 20(3):128-38. PubMed ID: 20599506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment: Sanctuary of the devil.
    Hui L; Chen Y
    Cancer Lett; 2015 Nov; 368(1):7-13. PubMed ID: 26276713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells.
    Castro-Vega LJ; Jouravleva K; Ortiz-Montero P; Liu WY; Galeano JL; Romero M; Popova T; Bacchetti S; Vernot JP; Londoño-Vallejo A
    Carcinogenesis; 2015 Oct; 36(10):1180-92. PubMed ID: 26168819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and significance of MicroRNAs in benign and malignant human stem cells.
    Utikal J; Abba M; Novak D; Moniuszko M; Allgayer H
    Semin Cancer Biol; 2015 Dec; 35():200-11. PubMed ID: 26192966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.